PetMed ExpressPETS
About: PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
Employees: 287
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
14.23% less ownership
Funds ownership: 60.02% [Q2] → 45.79% (-14.23%) [Q3]
17% less call options, than puts
Call options by funds: $493K | Put options by funds: $597K
20% less funds holding
Funds holding: 115 [Q2] → 92 (-23) [Q3]
31% less capital invested
Capital invested by funds: $50.1M [Q2] → $34.7M (-$15.4M) [Q3]
68% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 34
74% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 53
Research analyst outlook
We haven’t received any recent analyst ratings for PETS.
Financial journalist opinion
Based on 7 articles about PETS published over the past 30 days
